Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

抗人T细胞兔免疫球蛋白 - NMPA Drug Approval Details

Approvals/NMPA/Anti-human T Lymphocyte Rabbit Immunoglobulin

Approved

生物制品

Anti-human T Lymphocyte Rabbit Immunoglobulin

NEOVII Biotech GmbH🇨🇳 National Medical Products Administration

Approval Date: Nov 28, 2019
Approval ID: 7LeagR71jya
Company: NEOVII Biotech GmbH
Type: 生物制品

Approval Details

Approval Id: 7LeagR71jya
Approval Number: 国药准字J20150042
Generic Name: 抗人T细胞兔免疫球蛋白
Generic Name En: Anti-human T Lymphocyte Rabbit Immunoglobulin
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 100毫克(5毫升)/瓶
Reg Date: 2019-11-28
Company Name: NEOVII Biotech GmbH
Company Address: Am Haag 6+7,82166,Grafelfing, Germany
Production Company Name: NEOVII Biotech GmbH
Production Company Address: Am Haag 6+7,82166,Grafelfing,Germany
Company Detail Path: /organization/neovii-biotech-gmbh
Production Company Detail Path: /organization/neovii-biotech-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 28, 2019

Approval ID

7LeagR71jya

Type

生物制品

Back to NMPA Approvals